PHVS Stock Analysis: Buy, Sell, or Hold?
PHVS - Pharvaris N.V. Ordinary Shares
$35.07
0.00 (0.00%)
▲
5d:
+5.57%
30d:
+11.3%
90d:
+31.69%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
27d
Get Alerted When PHVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PHVS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: PHVS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PHVS is currently trading at $35.07, which is considered extended relative to its 30-day fair value range of $30.85 to $34.43.
Technical Outlook: Technically, PHVS is in a strong uptrend. Immediate support is located at $33.00, while resistance sits at $36.60.
Market Sentiment: PHVS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $46.53 (+32.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PHVS is in a strong uptrend. Immediate support is located at $33.00, while resistance sits at $36.60.
Market Sentiment: PHVS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $46.53 (+32.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$30.85 -
$34.43
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 32.7% below Wall St target ($46.53)
Trading Range Analysis
30-Day Trading Range
$30.85 -
$34.43
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$33.00
Resistance Level
$36.60
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.92
Wall Street Target
$46.53
(+32.7%)
Share & Embed Analysis
Last updated: July 13, 2026 8:06 PM ET
Data refreshes hourly during market hours. Next update: 9:06 PM
Data refreshes hourly during market hours. Next update: 9:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Anne Lesage
SELL
100 shares
2026-04-23
Johannes Gerardus Chri S…
SELL
100 shares
2026-04-23
Peng Lu
SELL
100 shares
2026-04-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 64 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 57 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
Advanced PHVS Option Strategies
Professional options setups generated by AI based on today's PHVS price and gamma walls.
